Searchable abstracts of presentations at key conferences in endocrinology

ea0028p36 | Clinical biochemistry | SFEBES2012

Hyperprolactinaemia secondary to an unusual coincidence of macroprolactin and a pituitary lesion- a case report

Narayanan Deepa , Waise Ahmed

Introduction: Prolactinoma and macroprolactin are important differentials in the diagnosis of hyperprolactinaemia. We present the case history of a patient with hyperprolactinaemia due to an unusual coincidence of macroprolactin and a non-enhancing pituitary lesion. Case history: A previously well female police officer aged 29, was referred to the endocrine clinic with a history of amenorrhoea and mastalgia for 3 years. She also complained of nausea, dizziness, weight gain, th...

ea0025p32 | Clinical biochemistry | SFEBES2011

Significance of insulin-C-peptide ratio in the diagnostic algorithm for endogenous hyperinsulinaemia

Sugunendran Suma , Narayanan Deepa , Shafiq Waqas , Malik Mohamed , Sathyapalan Thozhukat

Background: Insulin, derived from a single chain precursor pro-insulin, is cleaved by convertases to form insulin (t1/2 – 4 min) and C-peptide (t1/2 – 30 min). The ratio of insulin to C-peptide levels, which is usually less than one, is reversed in presence of exogenous insulin and insulin autoimmune syndrome. We present the significance of insulin-C-peptide ratio (ICR) in the diagnostic algorithm for the investigation of endogenous hyperinsulinaemia.<p class="ab...

ea0021p59 | Clinical practice/governance and case reports | SFEBES2009

The use of insulin stress test as an assessment of tiredness

Dampetla Srilatha , Ng Jen , Narayanan Deepa , Kilpatrick Eric , Atkin Stephen

Background: The insulin stress test (IST) is accepted as the gold standard investigation of the hypothalamio-pituitary–adrenal axis (HPA). The short synacthen test (SST) has been advocated as an alternative to the IST. Fatigue can be a common presenting symptom of patients suffering from abnormalities in the HPA axis.Methods: We audited the results of ISTs following failed SSTs for the assessment of patients who present with symptoms of fatigue. We ...

ea0094p185 | Bone and Calcium | SFEBES2023

A retrospective audit of patients with fragility hip or vertebral fracture - assessing suitability for romosozumab

Batten Lucy , Melrose Rachel , Narayanan Deepa , Aye Mo

Introduction: The current UK guidelines (NICE TA791) recommend the use of romosozumab, a monoclonal sclerostin inhibitor, for patients at high imminent risk of fragility fractures. However, elderly patients with a very high risk of fractures often exhibit frailty and other comorbidities. This retrospective survey was conducted in a major trauma centre in northern England to evaluate the potential utilisation of romosozumab in a real-world setting.<p class=...

ea0021p58 | Clinical practice/governance and case reports | SFEBES2009

Audit on the safety of the insulin stress tests in a tertiary endocrine referral centre

Ng Jen Min , Aye Myint , Ward Leanne , Narayanan Deepa , Atkin Stephen L , Kilpatrick Eric S

Background: The insulin stress test (IST) is accepted as the gold standard investigation of the hypothalamio-pituitary–adrenal axis (HPA). The test has been shown to be reliable though potentially unpleasant for the patient and has been associated with complications such as loss of consciousness, seizures, arrythmias, angina, myocardial infarction and death. To this effect close medical supervision is always required when an IST is performed.Methods...